Aspergillosis and mucormycosis - systemic mycoses of importance in COVID-19: Review article

• Autor(a) principal: Tavares, Ramiro Moreira
• Data de Publicação: 2021
• Outros Autores: Leite, Cicero Emanoel Alves, Tavares, Ravel Moreira, Oliveira, Patrícia Lopes, Quental, Ocilma Barros de
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Research, Society and Development
• Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/17101
• topic: Aspergillosis; Mucormycosis; Coronavirus infections.; Aspergilosis; Mucormicosis; Infecciones por coronavirus.; Aspergilose; Mucormicose; Infecções por Coronavirus.

Introduction: Invasive aspergillosis and mucormycosis are alarming infections in solid organ and hematopoietic cell transplant recipients. In the context of the pandemic caused by SARS-CoV2, cases of these conditions associated with increased hospital stay and dismal outcomes have been evidenced. Invasive fungal infections represent relevant entities in the care of critically ill patients affected by this coronavirus. Objective: to evaluate the importance of aspergillosis and mucormycosis in patients affected by COVID-19. Methodology: This is a narrative review study that is configured as a qualitative and exploratory study. To this end, an analysis of articles published in the PUBMED database was carried out, as well as of printed books on the subject. The terms used for the research were: “Aspergillosys”, “Mucormycosis” and “Coronavirus Infections”. Results: Invasive aspergillosis and mucormycosis are complications related to increased mortality in patients with COVID-19. Conclusion: Invasive aspergillosis and mucormycosis are entities with high mortality, representing a side effect that should be addressed early in cases of deterioration in the clinical condition of an individual undergoing treatment with corticosteroids and immunosuppressants with COVID-19.